Condition
Structural Heart Abnormality
Total Trials
7
Recruiting
3
Active
3
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 7 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
2Total
Not Applicable (2)
Trial Status
Recruiting3
Enrolling By Invitation2
Completed2
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT04787757Completed
Autonomous Robotics for Transcatheter Cardiac Procedures
NCT06462989Not ApplicableEnrolling By InvitationPrimary
Harnessing ECG Artificial Intelligence for Rapid Treatment and Accurate Identification of Structural Heart Disease
NCT05696522Not ApplicableRecruiting
Stereotactic Ablative Radiotherapy for the Treatment of Refractory Ventricular Tachycardia
NCT07020286Enrolling By InvitationPrimary
Prince of Wales Hospital Structural Heart Registry
NCT06315998RecruitingPrimary
Diagnosis of Structural Heart Disease Using MCG
NCT06137885Recruiting
REgiStry-based Cardiovascular qUality improvEment Research
NCT03429452CompletedPrimary
The SALMANTICOR Study
Showing all 7 trials